Covance and M2Gen have entered into an exclusive alliance and services agreement to offer patient recruitment services matching potential patients for biomarker-driven oncology trials with the right treatment. Also, Covance will serve as M2Gen’s preferred provider for DNA/RNA sequencing, gene expression analysis, and genotyping analysis services, which will be conducted at its genomics lab in Seattle, WA.   “Working together, Covance and M2Gen expect to help biopharmaceutical companies acc...